SAN FRANCISCO, Jan 13 (Reuters) - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs.
The companies did not disclose financial terms. In a press release, Modella AI said its "foundation models" and AI agents would be integrated into oncology research and development to support clinical development and biomarker discovery.
"Oncology drug development is becoming more complex, more data-rich and more time-sensitive," said Gabi Raia, Modella AI's chief commercial officer, adding that joining AstraZeneca would allow it to deploy its tools in global trials and clinical settings.
AstraZeneca said that this was the first acquisition of an AI firm by a big pharmaceutical company.
In an interview at the JP Morgan Healthcare Conference, AstraZeneca Chief Financial Officer Aradhana Sarin said the acquisition would "supercharge" the company's quantitative pathology and biomarker discovery efforts by bringing more data and AI capabilities in-house.
The deal was one of a number of pacts between major drug firms and AI companies that were unveiled at the healthcare conference, including a $1 billion collaboration between Nvidia and Eli Lilly. They plan to build a new research lab using Nvidia's latest-generation AI chips.
Modella will accelerate AstraZeneca’s efforts to make pathology more quantitative - using computers to analyze biopsies for relevant proteins and correlate them with clinical data - so AstraZeneca can develop “highly targeted biomarkers and then highly targeted therapeutics,” Sarin said.
The deal is an expansion of a multi-year collaboration that the companies unveiled in July.
Sarin said that partnership served as a "test drive," adding that AstraZeneca ultimately wanted Modella's data, foundation models and AI talent in-house.
She said AI tools could be used to more rapidly select patients for drug trials, which could increase the odds of clinical success and cut related costs.
(Reporting by Maggie Fick; Editing by Thomas Derpinghaus)
LATEST POSTS
- 1
Tire Brands for Senior Drivers: Guaranteeing Security and Solace - 2Manual for Tracking down the Immaculate Magnificence of Focal Asia
- 3Peloton recalls more than 800,000 bikes after broken seat posts injure users
- 4Artemis 2 astronauts reveal adorable zero-g indicator 'Rise' | Space photo of the day for March 31, 2026
- 5Which Instax Camera Would it be a good idea for you to Purchase?
- NASA launches science balloon in Antarctica | Space photo of the day for Dec. 22, 2025
- Astrophotographer captures rare footage of the Hubble Telescope crossing the sun (video)
- Discovery of ancient pleasure boat reveals Egypt's maritime history
- Flu season is ramping up, and some experts are "pretty worried"
- China's 1st reusable rocket explodes in dramatic fireball during landing after reaching orbit on debut flight
- Islamabad: Iran allows 20 Pakistani ships through Strait of Hormuz
- Falcon 9 rocket launches Starlink satellites before making 550th SpaceX landing (video)
- Farmers worry about rising cost of fertiliser
- Al-Sharaa denies he called for 80% of Syrians to return from Germany
